TABLE 2.
Participant characteristics (n=10)
| Characteristic | Participants*, n (%) |
|---|---|
| Asthma care provided by | |
| Family physician | 8 (80) |
| Allergist | 1 (10) |
| Parents/family member | 3 (30) |
| Comorbidities | |
| Allergies | 9 (90) |
| Allergic rhinitis | 4 (40) |
| Eczema | 4 (40) |
| Current smoking | 1 (10) |
| Current medications | |
| Short-acting beta agonist | 7 (70) |
| Inhaled corticosteroid | 5 (50) |
| Long-acting beta agonist | 1 (10) |
| Combined inhaled corticosteroid and long-acting beta agonist | 2 (20) |
| Leukotriene receptor antagonist | 1 (10) |
| Asthma control | |
| Previous ER visit(s) | 6 (60) |
| Previous hospital admission(s) | 4 (40) |
| Nocturnal asthma arousals (past week) | 3 (30) |
| Activity limitation due to asthma (past week) | 6 (60) |
| >3 puffs of rescue bronchodilator (past week) | 3 (30) |
| Agreed with statement: “It is important for people with asthma to use protective measures (eg, masks) in the workplace if asthma triggers are present” | 7 (70) |
| Agreed with statement: “Asthma has been an important factor in determining my choice of a future career” | 2 (20) |
*
Five subjects participated in phase 1, five in phase 2 (four of the five had also participated in phase 1 and four in phase 3). Thus, a total of 10 individuals participated in phases 1 to 3. ER Emergency room